Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy helps diagnose and track treatment for hair loss in men and women.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Alopecia areata patients have higher osteopontin levels and more eye changes, but their vision remains unaffected.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Minoxidil use was linked to a rare eye condition that improved after stopping the treatment.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

PC-associated alopecia has unique microscopic features.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Intracorneal vacuoles are common in parakeratotic skin diseases in dogs, especially with more parakeratosis.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

White hair follicles in vitiligo have fewer and less functional melanocytes.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Both treatments for resistant alopecia areata were equally effective.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.